戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ules, either niacin or salicylic acid, to an omega-3 fatty acid.
2 er of structured triacylglycerols containing omega-3 fatty acids.
3 echanism for the anti-inflammatory effect of omega-3 fatty acids.
4 n risk associated with intakes of long-chain omega-3 fatty acids.
5 ent anti-inflammatory mediators derived from omega-3 fatty acids.
6  total polyunsaturated fatty acids and total omega-3 fatty acids.
7 te LDL cholesterol for fibrates, niacin, and omega-3 fatty acids.
8 ries, and health effects of contaminants and omega-3 fatty acids.
9 ogenesis, which can be reversed with dietary omega-3 fatty acids.
10 r triglycerides include niacin, fibrates and omega-3 fatty acids.
11 nity of patients with Alzheimer's disease by omega-3 fatty acids.
12 d dietary intake of macular xanthophylls and omega-3 fatty acids.
13 ficacy can be increased by augmentation with omega-3 fatty acids.
14 ial therapeutic and prophylactic benefits of omega-3 fatty acids.
15 tion during the autoxidation of oils rich in omega-3 fatty acids.
16 ed for several covariates, including age and omega-3 fatty acids.
17 tribute to the salutary signaling actions of Omega-3 fatty acids.
18 s observed only in subjects with high plasma omega-3 fatty acids.
19 cy of hyperlipidemia and high intake of n-3 (omega-3) fatty acids.
20 arotenoids, tuna and dark-meat fish, or n-3 (omega-3) fatty acids.
21 ins B-12 and D, calcium, and long-chain n-3 (omega-3) fatty acids.
22 ing lipid mediators (SPMs) derived from n-3 (omega-3) fatty acids.
23  study demonstrated that oral consumption of omega-3 fatty acids (180 mg EPA and 120 mg DHA twice dai
24 eys fed docosahexaenoic acid, the long-chain omega-3 fatty acid abundant in neural membranes, had cor
25 , vitamin D, vitamin B-12, protein, and n-3 (omega-3) fatty acids, all of which have important roles
26 the omega-6 fatty acid linoleic acid and the omega-3 fatty acid alpha-linolenic acid.
27 een relational memory accuracy and intake of omega-3 fatty acids and a negative relation of both rela
28               Also, the relative increase in omega-3 fatty acids and alpha-tocopherol, from winter to
29 e effects of 4-17 month supplementation with omega-3 fatty acids and antioxidants (Smartfish drink; S
30                                          Its omega-3 fatty acids and EPA accounted for 33 and 10% of
31                 We evaluated whether dietary omega-3 fatty acids and fish consumption were associated
32 for the association of intakes of individual omega-3 fatty acids and fish with endometrial cancer ris
33 ve evaluated associations between long-chain omega-3 fatty acids and incidence of congestive heart fa
34 w microalga can be cultivated for long chain omega-3 fatty acids and lutein production in the tropica
35                         Systemic and topical omega-3 fatty acids and omega-6 fatty acids have been us
36                           The consumption of omega-3 fatty acids and phytosterol promotes the reducti
37                  The relation between marine omega-3 fatty acids and T2D was observed in hypertensive
38  produced significantly different amounts of omega-3 fatty acids and that these differences correlate
39 ship between baseline blood levels of marine omega-3 fatty acids and the rate of telomere shortening
40 key earlier intervention studies with marine omega-3 fatty acids and to review and comment on recent
41 omarkers that may regulate the metabolism of omega-3 fatty acids and ultimately affect their therapeu
42 as remained unclear why supplementation with omega-3 fatty acids and vitamin D improve cognitive func
43            Plasma concentrations of omega-3 (omega-3) fatty acids and homocysteine are associated wit
44  showed that higher baseline intakes of n-3 (omega-3) fatty acids and leucine are associated with pre
45 in the fresh vine leaves, linolenic acid (an omega-3-fatty acid) and quercetin-3-O-glucuronide (a pol
46       In particular, high dietary intakes of omega-3 fatty acids, and macular xanthophylls lutein and
47 K channels are thus receptors for long-chain omega-3 fatty acids, and these fatty acids--unlike their
48                                     Although omega-3 fatty acids appear to reduce hospital length of
49 creasing concentrations of vaccenic acid and omega-3 fatty acids, appeared more efficient for organic
50                In addition, plasma levels of omega-3 fatty acids are affected not only by dietary int
51 D ( approximately 70% of the population) and omega-3 fatty acids are common, suggesting that brain se
52                                              Omega-3 fatty acids are dietary essentials, and the curr
53                                              Omega-3 fatty acids are essential for healthy brain and
54 tural sources of triacylglycerols containing omega-3 fatty acids are of particular interest due to th
55                                              Omega-3 fatty acids are used in both nutraceuticals and
56                                         n-3 (omega-3) Fatty acids are associated with a reduced risk
57                 In addition, patients in the omega-3 fatty acid arm underwent significant reductions
58 AFLD to (a) establish the dose of long-chain omega-3 fatty acids as a treatment, (b) determine the du
59 ng has practical implications for the use of omega-3 fatty acids as nutraceuticals for the general pu
60                                              Omega-3 fatty acids attenuate the inflammatory response
61                                   Long-chain omega-3 fatty acids belong to a family of polyunsaturate
62 ew understanding regarding the complexity of omega-3 fatty acid biology is the purpose of this review
63 mperature, revealed by a slight reduction of omega-3 fatty acids, but neither accumulation of TBARS n
64 e potential for encapsulating and delivering omega-3 fatty acids, but they are typically fabricated f
65  also characterized the oxygenation of these omega-3 fatty acids by aspirin-treated huPGHS-2.
66 d in a large multicenter study, suggest that omega-3 fatty acids can be an effective, safe, and affor
67 These opposing effects of tissue omega-6 and omega-3 fatty acids can be eliminated by antibiotic trea
68 e across research with cytokine antagonists, omega-3 fatty acids, celecoxib, and exercise is that ant
69 04; P for trend = 0.057), and 0.51 for total omega-3 fatty acids (CI, 0.32 to 0.80; P for trend = 0.0
70  Enzymatically oxygenated derivatives of the omega-3 fatty acids cis-4,7,10,13,16,19-docosahexaenoic
71  of Immunity, Yan et al. (2013) suggest that omega-3 fatty acids commonly found in marine oils can su
72 ent analyses, the fish component of aMED and omega-3 fatty acids component of AHEI-2010 were inversel
73 ermore, the produced echium oil had the same omega-3 fatty acid composition than traditionally extrac
74               We investigated whether plasma omega-3 fatty acid concentrations (eicosapentaenoic acid
75             Circulating individual and total omega-3 fatty acid concentrations are associated with lo
76 -3 supplementation raised plasma and adipose omega-3 fatty acid concentrations but had no beneficial
77                             Similarly, serum omega-3 fatty acid concentrations were inversely associa
78 s analyzed according to tertiles of baseline omega-3 fatty acid concentrations.
79 ed fat content, and improved unsaturated and omega-3 fatty acid concentrations.
80  of an alteration in the ratio of omega-6 to omega-3 fatty acid consumption are increased production
81 ty acid consumption is markedly greater than omega-3 fatty acid consumption.
82 and the wild type revealed reductions in all omega-3 fatty acid-containing plastidic and extraplastid
83                           Adipose and muscle omega-3 fatty acid content increased after treatment; ho
84 e with a codon-optimized CrFAD7 restored the omega-3 fatty acid content of both plastidic and extrapl
85  a plastid-located desaturase may impact the omega-3 fatty acid content of extraplastidic lipids.
86 2.5h, 40 degrees C) successfully doubled the omega-3 fatty acid content to 43.20 mol%.
87               (1)H NMR was used to determine omega-3 fatty acid content, and GC-MS to characterize oi
88                                              omega-3 Fatty acids continue to be promoted as cardiopro
89 ts received oral supplementation with 4 g of omega-3 fatty acids daily (840 mg eicosapentaenoic acid/
90                Increased consumption of n-3 (omega-3) fatty acids decreases the incidence of coronary
91                                      Dietary omega-3 fatty acid deficiency produced correspondingly l
92 ation of bacterial lipopolysaccharides or by omega 3 fatty acid deficient diets), microglia resorted
93                                Resolvins are omega-3 fatty acid derived potent bioactive lipids that
94 diators such as nitrosylated-fatty acids and omega-3 fatty acid-derived products polarize plaque macr
95   These results show that CrFAD7 is the only omega-3 fatty acid desaturase expressed in C. reinhardti
96 tion or lentivirus-mediated expression of an omega-3 fatty acid desaturase, mfat-1, normalized blood
97 ice that express the fat-1 gene encoding for omega-3 fatty acid desaturase, which leads to an increas
98 port here that disruption of function of the omega-3 FATTY ACID DESATURASE7 (FAD7) enhances plant def
99 the activities of the microsomal omega-6 and omega-3 fatty acid desaturases, FAD2 and FAD3.
100 ts, the endoplasmic reticulum (ER)-localized omega-3 fatty-acid desaturases (Fad3) increase the produ
101 analyses identified the relatively innocuous omega-3 fatty acid DHA (docosahexaenoic acid), piracetam
102 CHD and major depression with sertraline and omega-3 fatty acids did not result in superior depressio
103                Dietary intake of the natural omega-3 fatty acid docosahexaenoic acid (DHA) has been i
104                               The long-chain omega-3 fatty acid docosahexaenoic acid (DHA) is present
105                                          The omega-3 fatty acid docosahexaenoic acid (DHA) similarly
106                           We report that the omega-3 fatty acid docosahexaenoic acid (DHA), in combin
107 ched in the visual pigment rhodopsin and the omega-3 fatty acid docosahexaenoic acid (DHA).
108                             By contrast, the omega-3 fatty acid docosahexaenoic acid derivative, neur
109 roduced by cytochrome P450 epoxygenases from omega-3 fatty acid docosahexaenoic acid, inhibit VEGF- a
110                                              Omega-3 fatty acids (docosahexaenoic acid [DHA] and eico
111 tigate the association of baseline levels of omega-3 fatty acids (docosahexaenoic acid [DHA] and eico
112  of antioxidants, zinc, and carotenoids with omega-3 fatty acids (docosahexaenoic acid and eicosapent
113 hort-term supplementation with high doses of omega-3 fatty acids does not result in any measurable ch
114 e transgenic conversion of tissue omega-6 to omega-3 fatty acids dramatically reduces endotoxemic and
115                    We sought to evaluate how omega-3 fatty acids during brain maturation can influenc
116                        Dietary enrichment in omega-3 fatty acids during pregnancy and lactation in mi
117 opment and recently published data regarding omega-3 fatty acid effects on arrhythmias, heart failure
118                                      Dietary omega-3 fatty acids (eg, alpha-linolenic acid) were inhi
119 (PGE3), derived from COX-2 metabolism of the omega-3 fatty acid eicosapentaenoic acid (EPA), inhibite
120                          The polyunsaturated omega-3 fatty acid eicosapentaenoic acid-derived resolvi
121 t include arachidonic acid-derived lipoxins, omega-3 fatty acid eicosapentaenoic acid-derived resolvi
122                      The availability of the omega-3 fatty acids eicosapentaenoic acid (EPA) and doco
123 imental studies suggests that the long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexa
124          Much evidence shows that the marine omega-3 fatty acids eicosapentaenoic acid and docosahexa
125                          The long chain n-3 (omega-3) fatty acids eicosapentaenoic acid (EPA) and doc
126 ween B vitamin treatment and plasma combined omega-3 fatty acids (eicosapentaenoic acid and docosahex
127 nd 8,12-iso-iPF(3alpha)-VI, derived from the omega-3 fatty acid, eicosapentaenoic acid (EPA).
128 ch source of the health promoting long-chain omega-3 fatty acids, eicosapentaenoic (EPA) and docosahe
129  (FFQ) to estimate intakes of 2 marine-based omega-3 fatty acids, eicosapentaenoic acid (EPA) and doc
130  are modulated by vitamin D and the 2 marine omega-3 fatty acids, eicosapentaenoic acid (EPA) and doc
131 s of arachidonic acid (20:4 omega-6) and the omega-3 fatty acids: eicosapentaenoic acid (22:5) and do
132 fecal transfer revealed that elevated tissue omega-3 fatty acids enhance intestinal production and se
133 vely regulates adiponectin and through which omega-3 fatty acids enhance the anti-inflammatory adipok
134 ocosahexaenoic acid (DHA), a polyunsaturated omega-3 fatty acid enriched in oily fish, contributes to
135 rget FA compositions (i.e., total oil, total omega-3 fatty acids, EPA and DHA) were highly accurate w
136 mprehensive lipidomics, we identify omega-3 (omega-3) fatty acid epoxides as new mast cell-derived li
137 ed risk of T2D with the intake of long-chain omega-3 fatty acids, especially with higher intakes (>/=
138    Docosahexaenoic acid (DHA, 22:6n-3) is an omega-3 fatty acid essential for proper brain developmen
139                         Supplementation with omega-3 fatty acids ex vivo showed that their action is
140 reat analysis, patients randomly assigned to omega-3 fatty acids experienced a significant reduction
141  of randomized, placebo-controlled trials of omega-3 fatty acid (FA) treatment of major depressive di
142  about the combined effects of iron and n-3 (omega-3) fatty acid (FA) supplementation on cognitive pe
143 id (DHA; 22:6n-3), a highly unsaturated n-3 (omega-3) fatty acid (FA) used in the formation of neural
144                                The essential omega-3 fatty acid family member docosahexaenoic acid (D
145 ygenation product derived from the essential omega-3 fatty acid family member docosahexaenoic acid.
146 m 10 muL of whole or skimmed milk containing omega-3 fatty acids (FAs) during 12, 24, 48, 72 and 96 h
147   Dietary fish oils, rich in long-chain n-3 (omega-3) fatty acids (FAs) [e.g., docosahexaenoic acid (
148 g evidence of the beneficial effects of n-3 (omega-3) fatty acids (FAs) on cardiometabolic risk facto
149  recent epidemiological study suggested that omega-3 fatty acid (fish oil) supplementation blunted ca
150  to investigate the therapeutic potential of omega-3 fatty acids for patients with homozygous sickle
151           DESIGN, SETTING, AND PATIENTS: The Omega-3 Fatty Acids for Prevention of Post-operative Atr
152        alpha-Linolenic acid (ALA) is an n-3 (omega-3) fatty acid found mostly in plant foods such as
153              Long-chain polyunsaturated n-3 (omega-3) fatty acids, found mainly in fish, have been po
154 was to evaluate whether intake of long-chain omega-3 fatty acids from diet and supplements is associa
155                                              Omega-3 fatty acids from fish oil have been associated w
156  have been extensively tested to concentrate omega-3 fatty acids from fish oils, under mild enzymatic
157                        Demand for long chain omega-3 fatty acids from non-fish source for vegetarians
158 t have potential to preferentially hydrolyze omega-3 fatty acids from structured triacylglycerols.
159 pathway by which the brain obtains essential omega-3 fatty acids from the circulation is through a so
160           Transfer of n-6 (omega-6) and n-3 (omega-3) fatty acids from the maternal diet into human m
161 mean difference of 0.57 days in favor of the omega-3 fatty acid group (95% confidence interval -5.05,
162 pentaenoic acid; group 1, n = 10) or without omega-3 fatty acids (group 2, n = 10).
163  with HM-lecithin inhibited the oxidation of omega-3 fatty acids >/=90% compared to those stabilized
164               In subjects with high baseline omega-3 fatty acids (>590 mumol/L), B vitamin treatment
165 s study was to investigate the links between omega-3 fatty acids, gut microbiome diversity and compos
166 n contrast, those with low levels of dietary omega-3 fatty acids had decreased functional connectivit
167                                Each of these omega-3 fatty acids has distinct biological effects that
168 efficacy of nonpharmaceutical interventions (omega-3 fatty acids) has been challenged.
169                                          The omega-3 fatty acids have anti-inflammatory and antidiabe
170 hanistic insights into the actions of marine omega-3 fatty acids have been gained.
171                                    Trials of omega-3 fatty acids have been performed at doses insuffi
172   In contrast, randomized clinical trials of omega-3 fatty acids have yielded mixed and inconsistent
173 ]; P for trend = 0.057) and total long-chain omega-3 fatty acids (HR, 0.70 [CI, 0.49 to 0.99]; P for
174 ation for absence of reports of lipases with omega-3 fatty acid hydrolyzing ability and suggests meth
175                                      Dietary omega-3 fatty acid (i.e. docosohexaenoic acid (DHA)) and
176 cosahexanoic acid (DHA) is the most abundant omega-3 fatty acid in brain, and, although it is conside
177 ap between actual and recommended intakes of omega-3 fatty acids in an environmentally friendly manne
178                            Studies of marine omega-3 fatty acids in atrial fibrillation and in cardia
179  alter the concentration of both omega-6 and omega-3 fatty acids in both mother and offspring, with c
180                                Enrichment of omega-3 fatty acids in cod liver oil via alternate opera
181 objective was to assess whether supplemental omega-3 fatty acids in conjunction with diet and exercis
182 ovascular health have been attributed to the omega-3 fatty acids in fish and fish oils, but toxic che
183 cosapentaenoic acid and docosahexanoic acid, omega-3 fatty acids in fish oil, has been associated wit
184 gency sources regarding the contaminants and omega-3 fatty acids in Great Lakes fish and fish consume
185  currently available on the concentration of omega-3 fatty acids in Great Lakes fish and their absorp
186  in modulating the metabolism of omega-6 and omega-3 fatty acids in maternal mouse livers.
187        Recent studies testing the effects of omega-3 fatty acids in NAFLD are showing promise and sug
188 icient methodology for the quantification of omega-3 fatty acids in oils rich in omega-6 fatty acids
189              In contrast, data are sparse on omega-3 fatty acids in the fish and their consumers.
190 respondingly low levels (50-55% decrease) of omega-3 fatty acids in the forebrain relative to rats co
191 ckness was inversely associated with dietary omega-3 fatty acids in those with impaired fetal growth
192                                              Omega-3 fatty acids increase the unfolded protein respon
193 with later ages, and the ratio of omega-6 to omega-3 fatty acids increased in the aged brain (week 56
194                      Activation of GPR120 by omega-3 fatty acids inhibits multiple inflammation casca
195                  Mothers in the lowest 5% of omega-3 fatty acid intake had a significant increase in
196 uggests that optimizing vitamin D and marine omega-3 fatty acid intake may help prevent and modulate
197                     In contrast, high marine omega-3 fatty acid intake may improve disease-specific s
198                                              Omega-3 fatty acid intake was assessed by using a food-f
199 ssociated with both forms of memory, whereas omega-3 fatty acid intake was selectively positively ass
200 nges associated with differences in lifetime omega-3 fatty acid intake.
201 ay be a viable natural emulsifier to deliver omega-3 fatty acids into food and beverage products.
202                            Dietary intake of omega-3 fatty acids is associated with a slower rate of
203           Increased dietary intake of marine omega-3 fatty acids is associated with prolonged surviva
204    Increased self-reported dietary intake of omega-3 fatty acids is associated with reduced risk of G
205 ential of membrane processing to concentrate omega-3 fatty acids is enhanced.
206                    Consumption of long-chain omega-3 fatty acids is known to decrease the risk of maj
207 nd serotonergic systems to sleep quality and omega-3 fatty acid levels.
208 drugs known to mitigate suicidality, such as omega-3 fatty acids, lithium and clozapine.
209  of atrophy among subjects with low baseline omega-3 fatty acids (<390 mumol/L).
210           However, oral supplementation with omega-3 fatty acids, lutein plus zeaxanthin, zinc, or be
211 ment effect was not significantly different (omega-3 fatty acids main effect HR, 1.18; 95% CI, 0.96-1
212                               Probiotics and omega-3 fatty acids may ameliorate disease progression.
213                                              Omega-3 fatty acids may influence human physiological pa
214 se results suggest that intake of long-chain omega-3 fatty acids may reduce risk of total and cancer-
215               There was an increase in total omega 3 fatty acids (n-3) in muscle tissue (from 63.6 to
216                          Although long-chain omega-3 fatty acid (n-3 FA) consumption estimated via fo
217                  Despite the perception that omega-3 fatty acids (n-3 FA) protect against breast canc
218                               The long-chain omega-3 fatty acids (n-3 FAs) docosahexaenoic acid (DHA)
219       Besides their health benefits, dietary omega-3 fatty acids (n-3 PUFAs) can impair host resistan
220 ts exposed to diets enriched or deficient in omega-3 fatty acids (n-3) during their brain maturation
221 ontents and decrease in the content of total omega-3 fatty acids (n-3) in comparison to raw fish fill
222 ndomly assigned 1:1 to 6 months of high-dose omega-3 fatty acids (n=180) or placebo (n=178).
223 have frequently focused on methylmercury and omega-3 fatty acids, not persistent pollutants such as p
224                                              Omega-3 fatty acids (O3-FAs) can be effective in decreas
225 on other factors including dietary intake of omega-3 fatty acids, obesity, and genotypes at CFH Y402H
226 ase in unsaturated fatty acid content namely omega-3 fatty acids of wheat chips samples.
227 teine-Arginine-Glutamic-acid-Lysine-Alanine) omega-3-fatty acid oil containing nanoemulsion system in
228        Early trials evaluating the effect of omega 3 fatty acids (omega-3 FA) reported benefits for m
229                                              Omega-3 fatty acids (omega-3 FAs), DHA and EPA, exert an
230                               Consumption of omega-3 fatty acids (omega-3's), whether from fish oils,
231                    It is well known that the omega-3 fatty acids (omega-3-FAs; also known as n-3 fatt
232                                              Omega-3 fatty acids (omega-3s) in vitro and in vivo and
233 id beta1-42 (Abeta1-42), but are improved by omega-3 fatty acids (omega-3s).
234 s been well ascertained, the position of the omega-3 fatty acid on the triacylglycerol backbone influ
235  humans with FOs and measured the effects of omega-3 fatty acids on adipocytes and macrophages in vit
236 ed the effects of high-dose, very-long-chain omega-3 fatty acids on adipose tissue inflammation and i
237 also suggested that the beneficial effect of omega-3 fatty acids on brain atrophy may be confined to
238 e differential effects of tissue omega-6 and omega-3 fatty acids on gut microbiota and metabolic endo
239                       However, the effect of omega-3 fatty acids on human protein metabolism is unkno
240 in-coupled receptor GPR120 is a receptor for omega-3 fatty acids on macrophages and fat cells.
241                     Recent studies of marine omega-3 fatty acids on morbidity of, and mortality from,
242 s of supplementation with B vitamins or n-3 (omega-3) fatty acids on depressive symptoms in cardiovas
243 lts were randomly assigned to receive either omega-3 fatty acids or corn oil for 8 wk.
244  result in either lower levels of long-chain omega-3 fatty acids or higher levels of long-chain omega
245 ole of mixed meals or carbohydrate, protein, omega-3 fatty acid, or antioxidant supplementation in mi
246 en V249I and rs2669845 and dietary intake of omega-3 fatty acids (P = .004 and P = .009, respectively
247 nd macaque brain and support the notion that omega-3 fatty acids play a crucial role in developing an
248                                      However omega-3 fatty acid preferences were found to be modest.
249                                              Omega-3 fatty acids prevent cardiac fibrosis and cardiac
250      This review focuses on new prescription omega-3 fatty acid products in development and recently
251 ders and suicidality (lithium, clozapine and omega-3 fatty acids), providing a means toward pharmacog
252                A study confirmed that marine omega-3 fatty acids reduce the inflammatory burden with
253                              The addition of omega-3 fatty acids reduced MCP-1 expression with no eff
254  the forebrain relative to rats consuming an omega-3 fatty acid replete diet.
255          Dietary supplementation with 4 g of omega-3 fatty acids results in a significant increase in
256 lternative medicines (including acupuncture, omega-3 fatty acids, S-adenosyl-L-methionine, St. John's
257      However, no lipases with preference for omega-3 fatty acids selectivity have yet been discovered
258  immune-modulating nutrients (eg, glutamine, omega-3 fatty acids, selenium, and antioxidants) has bee
259 trient composition of seafood, in particular omega-3 fatty acids, selenium, taurine, vitamins D and B
260 als with low to medium risk of bias compared omega-3 fatty acids, soy, ginkgo biloba, B vitamins, vit
261                    Evidence about effects of omega-3 fatty acids, soy, ginkgo biloba, folic acid alon
262 (SCARB1, ABCA1, ABCG5, and LIPC), long-chain omega-3 fatty acid status (ELOVL2, FADS1, and FADS2), an
263     RECENT FINDINGS: Studies relating marine omega-3 fatty acid status to current or future outcomes
264                                              Omega-3 fatty acids stimulate muscle protein synthesis i
265 on with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) trial was a secondary p
266                                   Long-chain omega-3 fatty acids such as docosahexaenoic acid (DHA) r
267                   Long-chain polyunsaturated omega-3 fatty acids such as docosahexaenoic acid (DHA),
268                                              Omega-3 fatty acid supplementation had no effect on the
269  systematic review, it can be concluded that omega-3 fatty acid supplementation of parenteral nutriti
270  of this study was to evaluate the effect of omega-3 fatty acid supplementation on the rate of muscle
271 uch as cardiovascular exercise, acupuncture, omega-3 fatty acid supplementation, and gluten-free diet
272 , compared with parenteral nutrition without omega-3 fatty acid supplementation.
273 te, valproate, aripiprazole, olanzapine, and omega-3 fatty acid supplementation.
274 e effect of a dietary intervention plus n-3 (omega-3) fatty acid supplementation on serum triglycerid
275              Randomized controlled trials of omega-3 fatty acid supplemented parenteral nutrition in
276  p = 0.008) was observed for those receiving omega-3 fatty acid supplemented parenteral nutrition, bu
277                    Our findings suggest that omega-3 fatty acid supplements offer protection against
278                                 In addition, omega-3 fatty acids suppressed the upregulation of adipo
279   Docosahexaenoic acid (DHA) is an essential omega-3 fatty acid that is critical to the formation of
280 d to take advantage of the health beneficial omega 3 fatty acids, the EGCG molecule was esterified wi
281 d clinical trial of lutein/zeaxanthin and/or omega-3 fatty acids, the Age-Related Eye Disease Study 2
282  no adverse events associated with high-dose omega-3 fatty acid therapy.
283 ss how the shift from a healthy diet rich in omega-3 fatty acids to a diet rich in saturated fatty ac
284  to potentially provide a complex mixture of omega-3 fatty acids to maximize cardiovascular risk redu
285 ed the previously reported benefit of marine omega-3 fatty acids towards mortality in survivors of my
286 d meats, and alcohol), and nutrient intakes (omega-3 fatty acids, trans fatty acids, total fiber, and
287                                              Omega-3 fatty acid treatment may have beneficial effects
288 h acute myocardial infarction with high-dose omega-3 fatty acids was associated with reduction of adv
289 A significant presence of the most important omega-3 fatty acids was detected.
290 ever, the content of total chemically intact omega-3 fatty acids was higher in the oil released from
291 mutant with more than 65% reduction in total omega-3 fatty acids was isolated by screening an inserti
292                                High baseline omega-3 fatty acids were associated with a slower rate o
293                                              Omega-3 fatty acids were not effective as an adjunct for
294                     Estimated food intake of omega-3 fatty acids were obtained from food frequency qu
295                   Marine but not plant-based omega-3 fatty acids were positively associated with inci
296                        Echium oil is rich in omega-3 fatty acids, which are important because of thei
297       Fish oil contains a complex mixture of omega-3 fatty acids, which are predominantly eicosapenta
298 hain fatty acids, including health-promoting omega-3 fatty acids, which have been implicated in the r
299 larly nutrients such as iron, zinc, and n-3 (omega-3) fatty acids, which play a role in brain structu
300  supplemental eicosapentanoic acid (EPA), an omega-3 fatty acid with immune and anabolic properties,
301 ignificant immune and biochemical effects of omega-3 fatty acids with antioxidants in patients with M
302 monstrates that BK channels are effectors of omega-3 fatty acids with marked tissue specificity.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top